VIUM
DEAD

Serial Number

86982214

Owner

VIUM, INC.

Attorney

David P. Johnson

First Use Date

May 4, 2016

Filing Date

Feb 9, 2016

Add to watchlist:

No watchlists yet
View on USPTO

VIUM Trademark

Serial Number: 86982214 • Registration: 5215140

VIUM is a trademark filed by VIUM, INC. on February 9, 2016. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

VIUM, INC. (3 trademarks)

441 BOREL AVENUE, SUITE 616
SAN MATEO, CA 94402

Entity Type: 03

RECURSION PHARMACEUTICALS, INC. (37 trademarks)

41 SOUTH RIO GRANDE STREET
SALT LAKE CITY, UT 84101

Entity Type: 03

Mousera, Inc. (5 trademarks)

411 Borel Avenue
San Mateo, CA 94402

Entity Type: 03

Trademark Details

Filing Date

February 9, 2016

Registration Date

May 30, 2017

First Use Anywhere

May 4, 2016

First Use in Commerce

May 4, 2016

Published for Opposition

August 9, 2016

Cancellation Date

December 15, 2023

Goods & Services

Laboratory animal breeding and preconditioning; genetic testing of animals; consulting services in the field of laboratory animal caretaking; surgical services; collection, organization, analysis, and reporting of medical data in connection with non-clinical trials and studies on pharmaceuticals

Laboratory analysis in the field of genotyping and phenotyping of animals, laboratory animal scientific research and testing; Laboratory research in the field of genotyping and phenotyping of animals; Scientific laboratory services; Scientific research and development; Scientific research consulting in the field of genotyping and phenotyping of animals; laboratory animal scientific research and testing; research and development of pharmaceuticals and biologics; scientific testing of pharmaceuticals and biologics; biopharmaceutical research design and scientific testing services; product safety testing for pharmaceuticals, biopharmaceuticals, and biologics; toxicological safety testing services for pharmaceuticals; animal medical research and testing services for the purpose of medical research; research and development of pharmaceuticals, biotechnology, and biochemicals; platform as a service (PAAS) featuring computer software platforms for conducting preclinical research in the field of animal scientific research and testing and development of pharmaceuticals; medical and scientific research, namely, designing, organizing, conducting, monitoring, and managing non-clinical trials and studies on pharmaceuticals for others; scientific consulting services for others in the field of non-clinical trials and studies on pharmaceuticals; collection, calibration, analysis and reporting of medical and scientific research data in connection with non-clinical trials and studies on pharmaceuticals; scientific research and analysis in the fields of bioinformatics, biomarkers and phenotyping; computer hardware and software design; development, updating and maintenance of software and databases; design and development of software for use in conducting animal and biological research in non-clinical pharmaceutical development studies; providing online computer databases in the fields of research and development of pharmaceuticals, biotechnology, and biochemicals; data mining; providing a website featuring technology enabling users to remotely track, monitor, analyze, and generate reports with information and statistics from non-clinical trials and studies on pharmaceuticals; scientific research and analysis in the field of pharmacology; advisory services in the field of pharmaceutical drug development, namely, selecting animal and biological research models for use in testing drugs; advisory services in the field of pharmaceutical drug development, namely, selecting biomarkers for use in testing drugs; lead candidate drug optimization services, namely, scientific research in the field of identifying compounds for drug development; providing medical and scientific information in the fields of biochemistry, pharmaceuticals; providing online non-downloadable software for designing, conducting, analyzing, and reporting animal studies

Filing History

CANCELLED SEC. 8 (6-YR)
Dec 15, 2023 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
May 30, 2022 REM1
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Aug 19, 2020 ASGN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 6, 2020 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 6, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 6, 2020 REAP
REVIEW OF CORRESPONDENCE COMPLETE - POWER OF ATTORNEY ENTERED
Apr 11, 2019 CORV
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Apr 11, 2019 EWAF
REGISTERED-PRINCIPAL REGISTER
May 30, 2017 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Apr 22, 2017 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Apr 21, 2017 CNPR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 21, 2017 EXRA
STATEMENT OF USE PROCESSING COMPLETE
Apr 20, 2017 SUPC
DIVISIONAL PROCESSING COMPLETE
Apr 20, 2017 DPCC
SOU EXTENSION 1 GRANTED
Apr 20, 2017 EX1G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Apr 20, 2017 AITU
USE AMENDMENT FILED
Mar 30, 2017 IUAF
DIVISIONAL REQUEST RECEIVED
Mar 30, 2017 DRRR
SOU EXTENSION 1 FILED
Mar 30, 2017 EXT1
TEAS REQUEST TO DIVIDE RECEIVED
Mar 30, 2017 ERTD
SOU TEAS EXTENSION RECEIVED
Mar 30, 2017 EEXT
TEAS STATEMENT OF USE RECEIVED
Mar 30, 2017 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 4, 2016 NOAM
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Aug 10, 2016 ASGN
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 9, 2016 NPUB
PUBLISHED FOR OPPOSITION
Aug 9, 2016 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 20, 2016 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jul 5, 2016 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 26, 2016 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 23, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 23, 2016 CRFA
ASSIGNED TO LIE
Jun 22, 2016 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 15, 2016 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 2, 2016 GNRN
NON-FINAL ACTION E-MAILED
Jun 2, 2016 GNRT
NON-FINAL ACTION WRITTEN
Jun 2, 2016 CNRT
ASSIGNED TO EXAMINER
May 25, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 12, 2016 NWOS
NEW APPLICATION ENTERED
Feb 12, 2016 NWAP